Avid Bioservices Inc (CDMO)

[biopharm]

I would focus on the science

Peregrine has come a long way since their early days and just like Deltagen. We can see better, all details.....than the early days when the FDA was not approving drugs based on (protein complex) better Biomarkers and how certain Biomarkers allow for that most optimal immune response. I don't mind the FDA failing to see the PS Targeting early on in the race and the race is far from over. Now since we have electronic solutions to keep up with the data being processed from biotech to off shore trading, I imagine things can change quicker than ever before.

"Deltagen Announces First Drug Development Target
From Its Research Pipeline

DT011M is a Specific and Key Player in Insulin Secretion

REDWOOD CITY, Calif., Jan. 31/PRNewswire-FirstCall/ — Deltagen, Inc. (Nasdaq: DGEN–news), announced today the identification of DT011M, a key insulin-mediating drug target, for the potential treatment of obesity and related diseases, such as diabetes. Deltagen has plans to initiate a chemical screening program and compound development efforts during 2002.

“Current drugs for diabetes seek to manage blood glucose level and do not address the underlying disorder. ...."
https://www.sec.gov/Archives/edgar/data/1034072/000089843002000648/dex991.htm